Affymax and Takeda to Commercialize Hematide™
By Business Review Editor
PharmaDeals Review: Vol 2006 Issue 69 (Table of Contents)
Published: 6 Mar-2006
DOI: 10.3833/pdr.v2006.i69.547 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Affymax entered into an exclusive licensing agreement with Takeda for the commercialization of Hematide™ in Japan...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: PharmaDeals Ltd
RSS